Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
1996-9-25
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0263-7103
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
808-9
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8761204-Anti-Inflammatory Agents,
pubmed-meshheading:8761204-Anticoagulants,
pubmed-meshheading:8761204-Arthritis, Rheumatoid,
pubmed-meshheading:8761204-Drug Therapy, Combination,
pubmed-meshheading:8761204-Heparin,
pubmed-meshheading:8761204-Humans,
pubmed-meshheading:8761204-Sulfasalazine
|
pubmed:year |
1996
|
pubmed:articleTitle |
Rheumatoid arthritis and heparin.
|
pubmed:publicationType |
Letter
|